• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON UNSPECFIED BD PHASEAL¿; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON UNSPECFIED BD PHASEAL¿; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Catalog Number UNKNOWN
Device Problems Leak/Splash (1354); Delivered as Unsterile Product (1421)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 05/27/2019
Event Type  malfunction  
Manufacturer Narrative
Unknown manufacturer: there are multiple bd locations where this unspecified bd device may have been manufactured.A catalog and lot number could not be confirmed for this incident and without this information we are unable to determine where the device was manufactured.(b)(4).Medical device expiration date: unknown.Device evaluated by mfr: a device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.Device manufacture date: unknown.
 
Event Description
It was reported that the unspecified bd phaseal¿ device began leaking from the y-site curos cap during a cytarabine infusion, and the cap was replaced and the infusion restarted.Around 30 minutes later, an alert went off and the phaseal device at the patient picc site was found opened, which had to be reconnected with pressure and a clamp.This complaint was created to capture the 1st of 5 related incidents.The following information was provided by the initial reporter: "observed pt continuous iv cytarabine infusion to be leaking from y-site curos cap.Cap replaced and infusion restarted uneventfully.Called into patient about a half hour later when beeping "downstream", phaseal at pt picc site was found to be open.Phaseal reconnected with some pressure and clamp placed, infusing without incident at present.".
 
Event Description
It was reported that the unspecfied bd phaseal¿ device began leaking from the y-site curos cap during a cytarabine infusion, and the cap was replaced and the infusion restarted.Around 30 minutes later, an alert went off and the phaseal device at the patient picc site was found opened, which had to be reconnected with pressure and a clamp.This complaint was created to capture the 1st of 5 related incidents.The following information was provided by the initial reporter: "observed pt continuous iv cytarabine infusion to be leaking from y-site curos cap.Cap replaced and infusion restarted uneventfully.Called into patient about a half hour later when beeping "downstream", phaseal at pt picc site was found to be open.Phaseal reconnected with some pressure and clamp placed, infusing without incident at present.".
 
Manufacturer Narrative
Correction: the original reporting rationale for sterility was incorrect, and has been updated to loose injector or separation of injector and mating component.The following field has been corrected: f.10.Device codes: 1354 h3 other text : see section h.10.
 
Manufacturer Narrative
H.6.Investigation summary: since no samples displaying the condition reported are available for examination, we were unable to fully investigate this incident and a root cause could be determined.A device history review could not be completed as no batch number was provided.Based on no sample, the investigation concluded, bd was not able to verify the indicated failure h3 other text : see section h.10.
 
Event Description
It was reported that the unspecfied bd phaseal¿ device began leaking from the y-site curos cap during a cytarabine infusion, and the cap was replaced and the infusion restarted.Around 30 minutes later, an alert went off and the phaseal device at the patient picc site was found opened, which had to be reconnected with pressure and a clamp.This complaint was created to capture the 1st of 5 related incidents.The following information was provided by the initial reporter: "observed pt continuous iv cytarabine infusion to be leaking from y-site curos cap.Cap replaced and infusion restarted uneventfully.Called into patient about a half hour later when beeping "downstream", phaseal at pt picc site was found to be open.Phaseal reconnected with some pressure and clamp placed, infusing without incident at present.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNSPECFIED BD PHASEAL¿
Type of Device
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
BECTON DICKINSON
1 becton drive
franklin lakes NJ 07417
MDR Report Key8732740
MDR Text Key149361788
Report Number2243072-2019-01261
Device Sequence Number1
Product Code ONB
Combination Product (y/n)N
PMA/PMN Number
UNKNOWN
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other,user facility
Type of Report Initial,Followup,Followup
Report Date 07/09/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue NumberUNKNOWN
Device Lot NumberUNKNOWN
Initial Date Manufacturer Received 05/31/2019
Initial Date FDA Received06/25/2019
Supplement Dates Manufacturer Received05/31/2019
05/31/2019
Supplement Dates FDA Received07/03/2019
07/09/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-